ABCD Antibodies is a spin-off company of the University of Geneva. It is part of a pioneering comprehensive strategy that promotes the widespread adoption of recombinant antibodies in research: The ABCD initiative (AntiBodies Chemically Defined). Their mission is to promote the widespread use of these superior products in the scientific community.
The complete initiative is composed of:
- The Geneva Antibody Facility (GAF)
- The ABCD Database
- ABCD Antibodies
- Antibody Reports